Cyanobacteria Scytonema javanicum and Scytonema ocellatum Lipopolysaccharides Elicit Release of Superoxide Anion, Matrix-Metalloproteinase-9, Cytokines and Chemokines by Rat Microglia In Vitro

Cosmopolitan Gram-negative cyanobacteria may affect human and animal health by contaminating terrestrial, marine and freshwater environments with toxins, such as lipopolysaccharide (LPS). The cyanobacterial genus Scytonema (S) produces several toxins, but to our knowledge the bioactivity of genus Scytonema LPS has not been investigated. We recently reported that cyanobacterium Oscillatoria sp. LPS elicited classical and alternative activation of rat microglia in vitro. Thus, we hypothesized that treatment of brain microglia in vitro with either cyanobacteria S. javanicum or S. ocellatum LPS might stimulate classical and alternative activation with concomitant release of superoxide anion (O2−), matrix metalloproteinase-9 (MMP-9), cytokines and chemokines. Microglia were isolated from neonatal rats and treated in vitro with either S. javanicum LPS, S. ocellatum LPS, or E. coli LPS (positive control), in a concentration-dependent manner, for 18 h at 35.9 °C. We observed that treatment of microglia with either E. coli LPS, S. javanicum or S. ocellatum LPS generated statistically significant and concentration-dependent O2−, MMP-9 and pro-inflammatory cytokines IL-6 and TNF-α, pro-inflammatory chemokines MIP-2/CXCL-2, CINC-1/CXCL-1 and MIP-1α/CCL3, and the anti-inflammatory cytokine IL-10. Thus, our results provide experimental support for our working hypothesis because both S. javanicum and S. ocellatum LPS elicited classical and alternative activation of microglia and concomitant release of O2−, MMP-9, cytokines and chemokines in a concentration-dependent manner in vitro. To our knowledge this is the first report on the toxicity of cyanobacteria S. javanicum and S. ocellatum LPS to microglia, an immune cell type involved in neuroinflammation and neurotoxicity in the central nervous system.

[1]  A. Mayer,et al.  Classical and Alternative Activation of Cyanobacterium Oscillatoria sp. Lipopolysaccharide-Treated Rat Microglia in vitro. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  W. Banks,et al.  Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit , 2015, Journal of Neuroinflammation.

[3]  S. Wood,et al.  Changes in saxitoxin-production through growth phases in the metaphytic cyanobacterium Scytonema cf. crispum. , 2015, Toxicon : official journal of the International Society on Toxinology.

[4]  R. Franco,et al.  Alternatively activated microglia and macrophages in the central nervous system , 2015, Progress in Neurobiology.

[5]  Sangdun Choi,et al.  Structure and Effects of Cyanobacterial Lipopolysaccharides , 2015, Marine drugs.

[6]  W. V. van Gool,et al.  Systemic inflammation and microglial activation: systematic review of animal experiments , 2015, Journal of Neuroinflammation.

[7]  S. Tajima,et al.  Inflammatory responses and potencies of various lipopolysaccharides from bacteria and cyanobacteria in aquatic environments and water supply systems. , 2015, Toxicon : official journal of the International Society on Toxinology.

[8]  N. Chen,et al.  Selective modulation of microglia polarization to M2 phenotype for stroke treatment. , 2015, International immunopharmacology.

[9]  R. Berisio,et al.  Chemistry of lipid A: at the heart of innate immunity. , 2015, Chemistry.

[10]  T. Boopathi,et al.  Impact of Environmental Factors on the Regulation of Cyanotoxin Production , 2014, Toxins.

[11]  M. O’Banion,et al.  Neuroinflammation and M2 microglia: the good, the bad, and the inflamed , 2014, Journal of Neuroinflammation.

[12]  Sangdun Choi,et al.  Gram-Negative Marine Bacteria: Structural Features of Lipopolysaccharides and Their Relevance for Economically Important Diseases , 2014, Marine drugs.

[13]  C. de Castro,et al.  Vibrio vulnificus MO6-24/O Lipopolysaccharide Stimulates Superoxide Anion, Thromboxane B2, Matrix Metalloproteinase-9, Cytokine and Chemokine Release by Rat Brain Microglia in Vitro , 2014, Marine drugs.

[14]  L. Bláha,et al.  The isolation and characterization of lipopolysaccharides from Microcystis aeruginosa, a prominent toxic water bloom forming cyanobacteria. , 2013, Toxicon : official journal of the International Society on Toxinology.

[15]  I. Bechmann,et al.  The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas , 2013, Clinical & developmental immunology.

[16]  R. Nau,et al.  Toll-like receptor stimulation increases phagocytosis of Cryptococcus neoformans by microglial cells , 2013, Journal of Neuroinflammation.

[17]  V. Perry,et al.  Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration , 2013, Seminars in Immunopathology.

[18]  Y. Pang,et al.  Intracerebral lipopolysaccharide induces neuroinflammatory change and augmented brain injury in growth-restricted neonatal rats , 2012, Pediatric Research.

[19]  Joshua A. Smith,et al.  Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases , 2012, Brain Research Bulletin.

[20]  Claire E. Geddes,et al.  Increased expression of the chemokines CXCL1 and MIP-1α by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats , 2011, Journal of Neuroinflammation.

[21]  K. Glaser,et al.  Cyanobacterial Microcystis aeruginosa lipopolysaccharide elicits release of superoxide anion, thromboxane B₂, cytokines, chemokines, and matrix metalloproteinase-9 by rat microglia. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  H. Kettenmann,et al.  Physiology of microglia. , 2011, Physiological reviews.

[23]  S. Wood,et al.  First report of saxitoxin production by a species of the freshwater benthic cyanobacterium, Scytonema Agardh. , 2011, Toxicon : official journal of the International Society on Toxinology.

[24]  R. Alizadeh,et al.  Extraction, Purification and Characterization of Lipopolysaccharide from Escherichia coli and Salmonella typhi , 2011, Avicenna journal of medical biotechnology.

[25]  D. Lantvit,et al.  Scytonemides A and B, cyclic peptides with 20S proteasome inhibitory activity from the cultured cyanobacterium Scytonema hofmanii. , 2010, Journal of natural products.

[26]  C. Colton,et al.  Assessing activation states in microglia. , 2010, CNS & neurological disorders drug targets.

[27]  G. Luheshi,et al.  Leptin modulates cell morphology and cytokine release in microglia , 2010, Brain, Behavior, and Immunity.

[28]  Jeak Ling Ding,et al.  Endotoxin detection--from limulus amebocyte lysate to recombinant factor C. , 2010, Sub-cellular biochemistry.

[29]  S. Franzblau,et al.  An antimicrobial guanidine-bearing sesterterpene from the cultured cyanobacterium Scytonema sp. , 2009, Journal of natural products.

[30]  C. Colton Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain , 2009, Journal of Neuroimmune Pharmacology.

[31]  Sang-H Choi,et al.  The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. , 2009, Trends in pharmacological sciences.

[32]  V. Perry,et al.  Microglial physiology: unique stimuli, specialized responses. , 2009, Annual review of immunology.

[33]  Jessica L. Teeling,et al.  Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: Underlying mechanisms , 2009, Neuroscience.

[34]  B. Jin,et al.  Interleukin-10 endogenously expressed in microglia prevents lipopolysaccharide-induced neurodegeneration in the rat cerebral cortex in vivo , 2007, Experimental & Molecular Medicine.

[35]  F. Crews,et al.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.

[36]  T. Kielian,et al.  Effects of low dose GM-CSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs) , 2007, Journal of Neuroinflammation.

[37]  M. Block,et al.  Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.

[38]  Ian Stewart,et al.  Cyanobacterial lipopolysaccharides and human health – a review , 2006, Environmental health : a global access science source.

[39]  S. Pflugmacher,et al.  Ecotoxicological effects of selected cyanobacterial secondary metabolites: a short review. , 2005, Toxicology and applied pharmacology.

[40]  M. Cheeran,et al.  Role of Microglia in Central Nervous System Infections , 2004, Clinical Microbiology Reviews.

[41]  M. Caroff,et al.  Structure of bacterial lipopolysaccharides. , 2003, Carbohydrate research.

[42]  S. Kyrylenko,et al.  Regulation of microglial inflammatory response by histone deacetylase inhibitors , 2003, Journal of neurochemistry.

[43]  L. Pannell,et al.  A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium. , 2003, Biochemistry.

[44]  H. Kettenmann,et al.  Interferon‐γ differentially modulates the release of cytokines and chemokines in lipopolysaccharide‐ and pneumococcal cell wall‐stimulated mouse microglia and macrophages , 2002 .

[45]  K. Kataoka,et al.  Lipopolysaccharide-induced microglial activation in culture: temporal profiles of morphological change and release of cytokines and nitric oxide , 1999, Neuroscience Research.

[46]  R. Simone,et al.  Opposite effects of interferon‐γ and prostaglandin E2 on tumor necrosis factor and interleukin‐10 production in microglia: A regulatory loop controlling microglia pro‐ and anti‐inflammatory activities , 1999, Journal of neuroscience research.

[47]  F. Shi,et al.  Neutralization of Macrophage Inflammatory Protein 2 (MIP-2) and MIP-1α Attenuates Neutrophil Recruitment in the Central Nervous System during Experimental Bacterial Meningitis , 1999, Infection and Immunity.

[48]  K. Glaser,et al.  Escherichia coli lipopolysaccharide potentiation and inhibition of rat neonatal microglia superoxide anion generation: correlation with prior lactic dehydrogenase, nitric oxide, tumor necrosis factor-alpha, thromboxane B2, and metalloprotease release. , 1999, Shock.

[49]  J. Whitaker,et al.  Expression of chemokine genes in rat glial cells: The effect of myelin basic protein‐reactive encephalitogenic T cells , 1997, Journal of neuroscience research.

[50]  T. Molitor,et al.  Differential production of and migratory response to beta chemokines by human microglia and astrocytes. , 1997, The Journal of infectious diseases.

[51]  R R Schumann,et al.  Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. , 1996, Current topics in microbiology and immunology.

[52]  U. Ikeda,et al.  Expression of cytokine-induced neutrophil chemoattractant in rat cardiac myocytes. , 1995, Journal of molecular and cellular cardiology.

[53]  G. Patterson,et al.  Scytophycin production by axenic cultures of the cyanobacterium Scytonema ocellatum. , 1994, Natural toxins.

[54]  S. Carmeli,et al.  Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance. , 1993, Cancer research.

[55]  H. Flad,et al.  Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells , 1991, Infection and immunity.

[56]  S. Carmeli,et al.  Tolytoxin and new scytophycins from three species of Scytonema. , 1990, Journal of natural products.

[57]  S. Sk Endotoxin detection and elimination in biotechnology. , 1986 .

[58]  S. Sharma,et al.  Endotoxin detection and elimination in biotechnology. , 1986, Biotechnology and applied biochemistry.

[59]  G. Kessler,et al.  The automated determination of NAD-coupled enzymes. II. Serum lactate dehydrogenase. , 1966, Clinical chemistry.